Compounding Pharmacy Linked To Infections Issues Recall

Law360, New York (August 12, 2013, 2:10 PM EDT) -- Specialty Compounding LLC on Friday recalled all of its sterile medications, following a warning issued by the U.S. Food and Drug Administration that at least 15 patients were sickened by one of the Texas compounding pharmacy's products.

Specialty, a subsidiary of Peoples Pharmacy Inc., said the recall was initiated after reports of bacterial infection affecting 15 patients at two Texas hospitals, Corpus Christi Medical Center Doctors Regional and Corpus Christi Medical Center Bay Area, whose treatment included intravenous infusions of calcium gluconate from Specialty Compounding....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.